|
000
| 02691nam 2200457zi 4500 |
|---|
| 001 | 9.920491 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20230321150238 |
|---|
| 006 | m o d f |
|---|
| 007 | cr mn||||||||| |
|---|
| 008 | 230301e202303 onc ob f000 0 eng d |
|---|
| 020 | |a9780660478470 |q(report) |
|---|
| 020 | |a9780660478487 |q(summary) |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aHP40-336/1-2023E-PDF |
|---|
| 086 | 1 |aHP40-336/2-2023E-PDF |
|---|
| 245 | 00|aInterim guidance on the use of pneumococcal 15-valent conjugate vaccine (PNEU-C-15) in pediatric populations. |
|---|
| 264 | 1|a[Ottawa] : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |cMarch 2023. |
|---|
| 264 | 4|c©2023 |
|---|
| 300 | |a1 online resource (29 pages) + |esummary (4 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Directives provisoires sur l'utilisation du vaccin conjugué 15-valent (PNEU-C-15) contre le pneumocoque dans les populations pédiatriques. |
|---|
| 500 | |aOn cover: An advisory committee statement (ACS), National Advisory Committee on Immunization (NACI). |
|---|
| 500 | |a"Pub.: 220797." |
|---|
| 500 | |a"Pub.: 220799." |
|---|
| 504 | |aIncludes bibliographical references (pages 18-20). |
|---|
| 650 | 0|aPneumococcal vaccine|zCanada. |
|---|
| 650 | 0|aVaccination of children|zCanada. |
|---|
| 650 | 0|aPneumococcal vaccine|xGovernment policy|zCanada. |
|---|
| 650 | 0|aVaccination of children|xGovernment policy|zCanada. |
|---|
| 710 | 2 |aPublic Health Agency of Canada, |eissuing body. |
|---|
| 710 | 1 |aCanada. |bNational Advisory Committee on Immunization, |eissuing body. |
|---|
| 775 | 08|tDirectives provisoires sur l'utilisation du vaccin conjugué 15-valent (PNEU-C-15) contre le pneumocoque dans les populations pédiatriques.|w(CaOODSP)9.920492 |
|---|
| 856 | 40|qPDF|s1.05 MB|uhttps://publications.gc.ca/collections/collection_2023/aspc-phac/HP40-336-1-2023-eng.pdf|z(report) |
|---|
| 856 | 40|qPDF|s558 KB|uhttps://publications.gc.ca/collections/collection_2023/aspc-phac/HP40-336-2-2023-eng.pdf|z(summary) |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/publications/vaccines-immunization/national-advisory-committee-immunization-interim-guidance-pneumococcal-15-valent-conjugate-vaccine-pneu-c-15-pediatric-populations.html|z(report) |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/publications/vaccines-immunization/national-advisory-committee-immunization-summary-interim-guidance-pneumococcal-15-valent-conjugate-vaccine-pneu-c-15-pediatric-populations-march-2023.html|z(summary) |
|---|